[1st clinical trials of a new topical combined preparation (flumethasone pyvalate, mineral pitch, salicylic acid) in chronic infiltrative skin diseases].
D005443:Flumethasone / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D011278:Pregnanes / Q000627:therapeutic use*; D012459:Salicylates / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy*; D013638:Tars / Q000627:therapeutic use*
D005938:Glucocorticoids; D011278:Pregnanes; D012459:Salicylates; D013638:Tars; D005461:Fluorine; D005443:Flumethasone
Prime esperienze cliniche con un nuovo preparato topico di associazione (pivalato di flumetasone, catrame minerale, acido salicilico) in dermopatie cronico-infiltrative.